Insulet | PODD - Market Capitalization

Stock Price
147.46
Daily Change
-1.22 -0.82%
Monthly
-26.81%
Yearly
-54.59%
Q2 Forecast
144.50

Insulet reported $10.63B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 178.41B 39.46B Mar/2026
Align Technology USD 12.28B 1.07B Mar/2026
AtriCure USD 1.43B 12M May/2026
Avanos Medical USD 1.14B 491M May/2026
Baxter International USD 8.67B 1.15B Mar/2026
Becton, Dickinson and Co. USD 44.45B 323M May/2026
Boston Scientific USD 93.26B 48.09B Mar/2026
Cardinal Health USD 49.72B 894M Mar/2026
Cooper Companies USD 15.95B 2.05B Dec/2025
Dexcom USD 24.17B 1.72B Mar/2026
Edwards Lifesciences USD 46.17B 3.3B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Globus Medical USD 11.52B 172M May/2026
ICU Medical USD 2.97B 551M May/2026
Insulet USD 10.58B 3.96B May/2026
Integra LifeSciences USD 1.04B 306M May/2026
J&J USD 579.15B 78.91B Mar/2026
Masimo USD 9.44B 85M May/2026
Merit Medical Systems USD 4.11B 1.11B Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Stryker USD 125.85B 8.57B Mar/2026
Tandem Diabetes Care USD 1.21B 278M May/2026
Teleflex USD 6.2B 901M May/2026
West Pharmaceutical Services USD 18.07B 1.73B Mar/2026
WK Kellogg Co USD 12.68B 1.35B May/2026
Zimmer Biomet Holdings USD 17.5B 321M Mar/2026